NHS2018年一年开出7000万次抗抑郁药处方,与十年前相比数量翻了一番

2019-04-01 不详 MedSci原创

根据NHS Digital的数据,去年英国开出的抗抑郁药物处方超过7000万,是十年前2008年记录的3600万的两倍。并且这些数字仅代表NHS处方,并不反映私人组织和医院中开出的处方。

根据NHS Digital的数据,去年英国开出的抗抑郁药物处方超过7000万,是十年前2008年记录的3600万的两倍。并且这些数字仅代表NHS处方,并不反映私人组织和医院中开出的处方。

NHS发言人表示:"虽然抗抑郁药对一些患者起着重要的作用,但'每生病一丸'的态度意味着很多人会服用他们并不需要的药物。”

"这就是为什么NHS正在推出替代药物的方法,例如1000名社会工作者为抑郁症患者提供适合他们病情的护理和建议,以及针对心理健康问题的谈话疗法计划,以解决抑郁和焦虑等常见疾病。"

同样,医生开出糖尿病药物治疗的近5500万次处方,十年内增加了69%,费用超过10亿英镑。

NHS目前非常重视社会处方,旨在通过初级保健网络社会处方计划减轻压力和不必要的药物处方。将初级保健患者与社区内的支持来源联系起来为医生提供非医疗转诊选项,与现有治疗一起改善人类健康和福祉,也减轻对医生和NHS的压力,并且成本远低于药物治疗。

原始出处:

http;//www.pharmatimes.com/news/nhs_prescribed_nearly_70m_antidepressants_last_year_as_rates_double_in_a_decade_1282924

本文系williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1722510, encodeId=e3e21e22510cc, content=<a href='/topic/show?id=7ff5549865a' target=_blank style='color:#2F92EE;'>#抑郁药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54986, encryptionId=7ff5549865a, topicName=抑郁药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78fa33270286, createdName=wetgdt, createdTime=Mon Dec 09 02:14:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492243, encodeId=de29149224346, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515272, encodeId=5a1d15152e27d, content=<a href='/topic/show?id=402a12e83da' target=_blank style='color:#2F92EE;'>#NHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12783, encryptionId=402a12e83da, topicName=NHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=626110750337, createdName=小几洁, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363980, encodeId=dd3636398074, content=大势所趋,护理行业发展的方向, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=650f104372, createdName=gcwu82, createdTime=Tue Apr 02 08:03:50 CST 2019, time=2019-04-02, status=1, ipAttribution=)]
    2019-12-09 wetgdt
  2. [GetPortalCommentsPageByObjectIdResponse(id=1722510, encodeId=e3e21e22510cc, content=<a href='/topic/show?id=7ff5549865a' target=_blank style='color:#2F92EE;'>#抑郁药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54986, encryptionId=7ff5549865a, topicName=抑郁药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78fa33270286, createdName=wetgdt, createdTime=Mon Dec 09 02:14:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492243, encodeId=de29149224346, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515272, encodeId=5a1d15152e27d, content=<a href='/topic/show?id=402a12e83da' target=_blank style='color:#2F92EE;'>#NHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12783, encryptionId=402a12e83da, topicName=NHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=626110750337, createdName=小几洁, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363980, encodeId=dd3636398074, content=大势所趋,护理行业发展的方向, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=650f104372, createdName=gcwu82, createdTime=Tue Apr 02 08:03:50 CST 2019, time=2019-04-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1722510, encodeId=e3e21e22510cc, content=<a href='/topic/show?id=7ff5549865a' target=_blank style='color:#2F92EE;'>#抑郁药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54986, encryptionId=7ff5549865a, topicName=抑郁药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78fa33270286, createdName=wetgdt, createdTime=Mon Dec 09 02:14:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492243, encodeId=de29149224346, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515272, encodeId=5a1d15152e27d, content=<a href='/topic/show?id=402a12e83da' target=_blank style='color:#2F92EE;'>#NHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12783, encryptionId=402a12e83da, topicName=NHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=626110750337, createdName=小几洁, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363980, encodeId=dd3636398074, content=大势所趋,护理行业发展的方向, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=650f104372, createdName=gcwu82, createdTime=Tue Apr 02 08:03:50 CST 2019, time=2019-04-02, status=1, ipAttribution=)]
    2019-04-03 小几洁
  4. [GetPortalCommentsPageByObjectIdResponse(id=1722510, encodeId=e3e21e22510cc, content=<a href='/topic/show?id=7ff5549865a' target=_blank style='color:#2F92EE;'>#抑郁药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54986, encryptionId=7ff5549865a, topicName=抑郁药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78fa33270286, createdName=wetgdt, createdTime=Mon Dec 09 02:14:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492243, encodeId=de29149224346, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515272, encodeId=5a1d15152e27d, content=<a href='/topic/show?id=402a12e83da' target=_blank style='color:#2F92EE;'>#NHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12783, encryptionId=402a12e83da, topicName=NHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=626110750337, createdName=小几洁, createdTime=Wed Apr 03 13:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363980, encodeId=dd3636398074, content=大势所趋,护理行业发展的方向, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=650f104372, createdName=gcwu82, createdTime=Tue Apr 02 08:03:50 CST 2019, time=2019-04-02, status=1, ipAttribution=)]
    2019-04-02 gcwu82

    大势所趋,护理行业发展的方向

    0

相关威廉亚洲官网

加拿大卫生部批准Otsuka/Lundbeck公司的REXULTI(brexpiprazole)用于重度抑郁症的辅助治疗

Otsuka和Lundbeck公司宣布,加拿大卫生部批准REXULTI(brexpiprazole)作为辅助抗抑郁药,用于对当前发作期间的现有抗抑郁治疗反应差的重度抑郁症(MDD)成人患者。

BMC Med.:考察妊娠期抗抑郁药与ASD和ADHD风险相关性的观察性研究有何局限?

2018年1月,发表在《BMC Med》的一项由英国科学家进行的观察性研究的系统评价,强调了评估妊娠期使用抗抑郁药与自闭症谱系障碍(ASD)和注意缺陷多动障碍(ADHD)的风险之间的相关性的观察性研究的方法学局限性。

NEJM病例:是谁,夺去了这位年轻女性的心跳?

“铃铃铃”,急诊室的电话突然响起,电话另一头传来一位女性急促的声音:“医生,快来救救我的女儿,她现在倒在地上,已经没有心跳了”。

PLoS One:抑郁和抗抑郁药对原发性胆汁性胆管炎临床疗效的影响

抑郁症在原发性胆汁性胆管炎(PBC)患者中普遍存在。笔者目的在于研究抑郁症和抗抑郁药对PBC患者肝预后的影响。

Lancet:一项研究指抗抑郁药有效:“平息了医学界一大争议”

据外媒报道,抗抑郁药究竟有没有效?研究者说,一项最新研究的结果,平息了医学界其中一个最大的争议

支持抗抑郁药的疗效的主要研究

一项针对最常见的抗抑郁药的大型综述发现,在治疗重度抑郁症时,它们都优于安慰剂,这可能会让人们对其有效性提出质疑。研究人员对21种用于严重抑郁症成人急性治疗的抗抑郁药的安慰剂对照和头对头试验的数据进行了系统评价和网络荟萃分析。发表在《柳叶刀》上的数据显示,研究中包含的所有抗抑郁药都比安慰剂更有效,但也突出了药物之间的关键区别。首先,优势比(衡量暴露与结局之间的关联)介于阿替西平2.13至瑞波西汀1.